Who invested in GateHouse Bio (fka sRNAlytics)?

Investors on record for GateHouse Bio (fka sRNAlytics): IndieBio.

Who founded GateHouse Bio (fka sRNAlytics)?

GateHouse Bio (fka sRNAlytics) was founded by David Salzman (founder and CEO).

GateHouse Bio (fka sRNAlytics)

WE ARE GATEHOUSE BIO We believe there is an RNA code that drives every disease Our mission is to find that code and use it to develop effective therapeutics Our Code-Breaker™ platform uses AI to decode the landscape of small RNAs (sRNAs) and digitally design biomarker-guided precision…

Health and bioIndieBio

Website: gatehousebio.com.

Category: Health and bio.

Domain age: 7 years.

On Recent Funding since: Oct 11, 2026.

About GateHouse Bio (fka sRNAlytics)

Recent Funding lists GateHouse Bio (fka sRNAlytics) under Health and bio. It went through IndieBio (IndieBio SF 06). It was founded by David Salzman.

Funding rounds

October 14, 2019
Website created
IndieBio SF 06
IIndieBio · batch
Source: indiebio.co

Founders and team

DS
David Salzman founder and CEO

LinkedIn · source: gatehousebio.com

Investors

IIndieBioaccelerator

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026

Questions and sources

GateHouse Bio (fka sRNAlytics): questions and answers

Who invested in GateHouse Bio (fka sRNAlytics)?: Investors on record for GateHouse Bio (fka sRNAlytics): IndieBio.
Who founded GateHouse Bio (fka sRNAlytics)?: GateHouse Bio (fka sRNAlytics) was founded by David Salzman (founder and CEO).

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gatehouse-bio-fka-srnalytics (get a free API key).